FDA approves zafirlukast, first of new type of asthma drug.
出版信息
Am J Health Syst Pharm. 1996 Dec 1;53(23):2778. doi: 10.1093/ajhp/53.23.2778.
PMID:8957338
Abstract
摘要
相似文献
1
FDA approves zafirlukast, first of new type of asthma drug.美国食品药品监督管理局批准了扎鲁司特，这是新型哮喘药物中的首个药物。
Am J Health Syst Pharm. 1996 Dec 1;53(23):2778. doi: 10.1093/ajhp/53.23.2778.
2
Zafirlukast for asthma.
Med Lett Drugs Ther. 1996 Dec 20;38(990):111-2.
3
Zafirlukast and Churg-Strauss syndrome.
JAMA. 1998 Jun 24;279(24):1949; author reply 1950.
4
Montelukast and zafirlukast in asthma.孟鲁司特和扎鲁司特在哮喘治疗中的应用
Drug Ther Bull. 1998 Sep;36(9):65-8.
5
Zafirlukast for chronic asthma: convenient and generally safe, but is it effective?
Ann Pharmacother. 1997 Sep;31(9):1084-6. doi: 10.1177/106002809703100921.
6
Summary of clinical trials with zafirlukast.扎鲁司特临床试验总结。
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 2):S238-45; discussion S245-8.
7
[A new oral therapy for the preventive treatment of asthma. Accolate: clinical profile].
J Pharm Belg. 1997 May-Jun;52(3):134.
8
[New drugs in asthma treatment. Leukotriene receptor blockers and leukotriene synthesis inhibitors].
Nord Med. 1997 Apr;112(4):122-5.
9
Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast.与使用白三烯受体拮抗剂扎鲁司特相关的哮喘转归变化。
Manag Care Interface. 2001 Feb;14(2):62-6.
10
A new treatment option in asthma management.
Community Nurse. 1998 Jul;4(6):23-4.
Zotero 插件